zahra pournasiri

Dr. zahra pournasiri


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2022 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ZPzahra pournasiri
zahra pournasiri
AMAbbas Madani
Abbas Madani
FNFatemeh Nazarpack
Fatemeh Nazarpack
John SayerJohn Sayer
John Sayer
ZCZahra Chavoshzadeh
Zahra Chavoshzadeh
MJMahnaz Jamee
Mahnaz Jamee

27 August 2011 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
AAArezoo Aghakhani
Arezoo Aghakhani
MBMohammad Banifazl
Mohammad Banifazl
NINabiallah Izadi
Nabiallah Izadi
WMWilli McFarland
Willi McFarland
MSMasoomeh Sofian
Masoomeh Sofian
ARAmitis Ramezani
Amitis Ramezani

17 August 2016 in Journal of Comprehensive Pediatrics
Verified
Journal Article
Open access
PDF file
ZPzahra pournasiri
zahra pournasiri
Introduction: Renal vein entrapment, named nutcracker phenomenon, is a contraction of renal vein between abdominal aorta and superior mesenteric artery. Patients can be asymptomatic or clinically manifested, called nutcracker syndrome. Proteinuria, hematuria, flank pain, varicocele in males and pelvic congestion in females are reported in such patients. Case Presentation: The current report presented an eight-year-old girl with microscopic hematuria and chronic abdominal pain along with short review of anatomy, pathophysiology, clinical significance and management of this syndrome. Conclusions: The nutcracker syndrome should be differentiated from unexplained chronic abdominal pain. Keywords: Renal Nutcracker Syndrome; Abdominal Pain; Hematuria; Child

1 March 2012
Verified
Journal Article
Closed access
ADAnahita Sanaei Dashti
Anahita Sanaei Dashti
AKAbdollah Karimi
Abdollah Karimi
VJVadood Javadi
Vadood Javadi
FSFarideh Shiva
Farideh Shiva
FFFatemeh Fallah
Fatemeh Fallah
ZPzahra pournasiri
zahra pournasiri

16 December 2023 in Iranian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
AMAsieh Mosallanejad
Asieh Mosallanejad
ZPzahra pournasiri
zahra pournasiri
HSHedyeh Saneifard
Hedyeh Saneifard
ASArmin Shirvani
Armin Shirvani
MFMaryam Forati
Maryam Forati
Background: Children with type 1 diabetes are at risk of developing microvascular and macrovascular complications, with diabetic nephropathy (DN) being a significant microvascular complication. Microalbuminuria is a crucial diagnostic marker for the early detection of DN and can predict the risk of vascular complications. Objectives: This study aimed to investigate the relationship between microalbuminuria and body mass index (BMI), changes in hemoglobin A1c (HbA1c), and the age of disease onset in children and adolescents with type 1 diabetes. Methods: This cross-sectional study was conducted in Mofid and Imam Hossein hospitals in Tehran, Iran, within 2021 - 2022. This study included 120 children and adolescents aged 5 - 20 years who had been diagnosed with type 1 diabetes for at least 3 years. All patients underwent evaluation for microalbuminuria, and its association with BMI, HbA1c levels, and the age of diabetes onset was assessed. Results: Among the 120 patients, 51% were female. Microalbuminuria was present in 15% of patients; however, 13.3% were overweight or obese. Furthermore, 91% of patients had HbA1c levels above 7%. The mean age of diabetes onset was 13 years, and the mean disease duration was 5.5 years. The study revealed a significant association between microalbuminuria and HbA1c levels, BMI, and the age of diabetes onset (P-values < 0.05). Conclusions: Microalbuminuria showed a positive correlation with increased BMI and poorer glycemic control. An early age of diabetes onset was identified as a risk factor for microalbuminuria in children and adolescents with diabetes.

9 January 2021 in Archives of Pediatric Infectious Diseases
Verified
Journal Article
Open access
PDF file
MMMasoumeh Mohkam
Masoumeh Mohkam
MMMahbube Mirzaee
Mahbube Mirzaee
FGFatemeh Abdollah Gorgi
Fatemeh Abdollah Gorgi
STSedigheh Rafiei Tabatabaei
Sedigheh Rafiei Tabatabaei
AKAbdollah Karimi
Abdollah Karimi
FKFereshteh Karbasian
Fereshteh Karbasian
Background: Information about renal involvement in pediatric patients with COVID-19 is limited, and there is not enough data about renal and urinary tract involvement in children infected with this novel virus. Objectives: This study aimed to determine the spectrum of kidney diseases in pediatric patients with COVID-19, admitted to a tertiary children’s hospital. Methods: This cross-sectional study was conducted on 71 pediatric patients with COVID-19 infection. Diagnosis of COVID-19 was established based on the guidelines by the Iranian Ministry of Health. The patients’ demographic characteristics, clinical symptoms, laboratory results, and renal ultrasonography findings were extracted from the hospital medical records. Results: On admission, 10% of patients had oliguria, 7.7% had edema, and 3% had hypertension. The first urinalysis indicated proteinuria, leukocyturia, and hematuria in 46%, 24%, and 23% of the patients, respectively. Overall, 40.7% of the patients showed some degree of renal involvement. During hospitalization, acute kidney injury (AKI) occurred in 34.5% of the patients. Based on the pediatric risk, injury, failure, loss of kidney function, and end-stage kidney disease (pRIFLE) classification, stage I (risk group) was found in 20% of patients, stage II (injury group) in 25% of patients, and stage III (failure group) in 55% of patients with AKI. The total mortality rate was estimated at 12.67%, and the incidence of in-hospital death was 30% in pediatric patients with severe COVID-19 infection associated with AKI. Conclusions: The prevalence of AKI was high in patients with COVID-19 infection hospitalized in our tertiary hospital. We also found that a decrease in renal function was associated with a higher risk of mortality. Overall, early detection of AKI and effective treatment may help reduce mortality in patients with COVID-19.